Showing results (1-10 of 279) with videos related to
Sort By:
Pageof 28
Current Opinion in Oncology|August 7, 2015
Targeting the programmed death-1/programmed death-ligand 1 axis in lymphomaChan Yoon Cheah, Nathan H Fowler, Sattva S NeelapuBest Practice & Research. Clinical Haematology|February 18, 2018
Novel agents for relapsed and refractory follicular lymphomaChan Yoon Cheah, Nathan H FowlerOncotarget|July 11, 2018
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysisDai Chihara, Nathan H Fowler, Yasuhiro Oki, et al.Current Hematologic Malignancy Reports|April 29, 2010
Vaccination strategies in follicular lymphomaShibichakravarthy Kannan, Sattva S NeelapuCurrent Oncology Reports|March 29, 2019
Chimeric Antigen Receptor-Engineered T Cell Therapy in LymphomaPaolo Strati, Sattva S NeelapuMolecular Oncology|November 10, 2015
Cancer immunotherapy: Strategies for personalization and combinatorial approachesVishwanath Sathyanarayanan, Sattva S NeelapuBest Practice & Research. Clinical Haematology|September 15, 2018
The promise of CAR T-cell therapy in aggressive B-cell lymphomaRanjit Nair, Sattva S NeelapuOncoimmunology|May 9, 2014
Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1+ T-cell subsetsFuliang Chu, Sattva S NeelapuPageof 28